insights_auto
Bakit tumaas ang DSKYF 5.66%?
Tingnan ang Higit pang Detalyechevron_right
DSKYF:OTCMKTS
Daiichi Sankyo Co Ltd
$17.08
arrow_upward
+5.66%(+0.92) 1D
Okt 15, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa DSKYF...
Buksan
$16.16
Mataas
$17.08
Mababa
$16.16
Mkt. cap
31.35B
Avg. na dami
3.48K
Dami
54.23K
Mataas nang 52-wk
$29.10
Mababa nang 52-wk
$13.85
Beta
-1.13
Mga natitirang share
1.86B
Bilang ng mga empleyado
20K
Buksan
$16.16
Mataas
$17.08
Mababa
$16.16
Mkt. cap
31.35B
Avg. na dami
3.48K
Dami
54.23K
Mataas nang 52-wk
$29.10
Mababa nang 52-wk
$13.85
Beta
-1.13
Mga natitirang share
1.86B
Bilang ng mga empleyado
20K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
ad-hoc-news.de
·
4 oras ang nakalipas
Nomura keeps JPY 3,800.00 target for Daiichi Sankyo stock
Profile
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
Tungkol sa Daiichi Sankyo Co Ltd
CEOHiroyuki Okuzawa
Mga Empleyado20.2K
ItinatagSet 28, 2005
HeadquartersChūō, Tokyo, Japan
Sektor-
Websitedaiichisankyo.co.jp